RESEARCH - 4137 Anuncios

Thursday 14 August 2025

Cantidad : 1kg; 25kg;

Cyanoacetic acid, a compound with the formula NCCH2COOH, was first synthesized in the late 19th century as chemists explored derivatives of acetic acid. Cyanoacetic acid is characterized by the presence of both a cyano group (CN) and a carboxyl group (COOH), making it a versatile...

Thursday 14 August 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 50mg*10via - Precio : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 40mg*10via - Precio : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 20mg*10via - Precio : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Methyl-2-pentanone (methyl isobutyl ketone) reagent is widely used as a solvent in chemical and pharmaceutical industries, separation and recovery of nuclear fission products, and scientific research experiments. 4-Methyl-2-pentanone is used as a solvent for nitrocellulose, lacquer...

Wednesday 13 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 12 August 2025

Cantidad : 1kg; 25kg;

NAD plays a central role in cellular energy metabolism, participating in glycolysis, the citric acid cycle, and oxidative phosphorylation. It transfers electrons to convert the energy generated during metabolism into ATP. Levels of NAD+ decline with age. Supplementing with NAD+ precursors...

Tuesday 12 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 12 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 12 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday 09 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday 09 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday 09 August 2025

Cantidad : 1kg; 25kg;

Citicoline Sodium is an essential intermediate in the synthesis of the major phospholipid of the cell membranes, phosphatidylcholine (PtdCho). It increases plasma adrenocorticotropic hormone (ACTH) levels and potentiates serum thyrotrophin (TSH) levels by activating the central cholinergic...

Saturday 09 August 2025

Cantidad : 1kg; 25kg;

Taxifolin, a chemical substance extracted from pine plants such as larch and Douglas fir. It belongs to the bioflavonoid pseudo-vitamin P, and its scientific name is dihydroquercetin. Japanese scholar Fukui first isolated it from the leaves of conifers (Chamaecyparis obtusa), and...

Friday 08 August 2025

PNC-27 is a chimeric p53 osmotin peptide that binds to HDM-2 in a p53 peptide-like structure, inducing selective membrane pore formation and causing cancer cell lysis. It is an anticancer peptide that can be used in acute myeloid leukemia research CAS：1159861-00-3 Ubicación : No. 10-11...

Friday 08 August 2025

Epitalon (also known as Epithalon or Epithalone) is the synthetic version of the polypeptide Epithalamin which is naturally produced in the pineal gland. It was synthesized by Vladimir Khavinson, a Russian professor and gerontologist, whose research focused on the development of peptide...

Wednesday 06 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 05 August 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 05 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 05 August 2025

Dimethocaine is an organic synthesis intermediate and pharmaceutical intermediate, mainly used in laboratory research and development processes and chemical and pharmaceutical production processes. Brand: Soarwin CAS No.: 94-15-5 EC Number: 1592732-453-0 Molecular Formula: C16H26N2O2 Density: 1...

Saturday 02 August 2025

Cantidad : 1kg; 25kg;

3-Quinuclidinone hydrochloride is an organic synthesis intermediate and a pharmaceutical intermediate. It can be used in laboratory organic synthesis processes and chemical pharmaceutical research and development processes. It is mainly used to synthesize an intermediate of azasetron...

Friday 01 August 2025

Cantidad : 1kg; 25kg;

Tetrahydropapaverine (Norlaudanosine) is a type of TIQs, an analog of salsolinol and tetrahydropapaveroline, and has neurotoxic effects on dopamine neurons. Used as an intermediate in the synthesis of atracurium besylate. Utilized in biological research and drug development. Brand...

Friday 01 August 2025

Cantidad : 1kg; 25kg;

- -1-Phenyl-1,2,3,4-tetrahydroisoquinoline is primarily used as an intermediate in the synthesis of pharmaceutical compounds. It is a key intermediate in the production of solifenacin succinate, a drug used to treat overactive bladder symptoms. Additionally, it is used in the synthesis...

Friday 01 August 2025

Cantidad : 1kg; 25kg;

1-Phenyl-1,2,3,4-tetrahydroisoquinoline is primarily used as an intermediate in the synthesis of various pharmaceutical compounds. It is particularly important in the preparation of solifenacin succinate, an antimuscarinic drug used to treat overactive bladder symptoms. It is also...

Friday 01 August 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...